Pediatric Bone Marrow Transplant News2014 | 2013 | | 2011 | 2010 | 2009 | 2008
For many children with high-risk or chemotherapy-refractory leukemia, allogeneic hematopoietic stem cell transplantation is the standard of care. Over the past decade, transplantation techniques have advanced and more patients than ever are now completely cured of their cancer. But the procedure is still an ordeal for many young patients and their families, often involving a long tense wait for a bone marrow match, substantial complications, and no guarantee of success.
That’s why researchers here at Seattle Cancer Care Alliance (SCCA) and Fred Hutchinson Cancer Research Center (FHCRC) are continually refining transplantation methods for leukemia. In this issue learn about our emerging strategies that promise to improve transplant outcomes in three
- Ensuring Patient Access
- Reducing the Risk of Graft Versus Host Disease (GVHD)
- Improving Treatment of Relapse
Since the first successful bone marrow transplants of the 1970s, much has been learned about the elements of care required for long-term effectiveness and safety. Today, we have transplant protocols suited for pediatric patients with all types of blood disorders and varying degrees of donor match. We have new treatments to boost survival and quality of life. And, based on three decades of research on some truly inspirational patients, we have a storehouse of evidence to guide the next decade of pediatric transplantation.
In this issue, read about:
2014 | 2013 | | 2011 | 2010 | 2009 | 2008